Home β€Ί Stock analysis β€Ί HKPD

Cellyan Biotechnology (HKPD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

HKPD ends flat (+0.2%) to $0.11. Closed at $0.11, +0.18% vs the prior close of $0.11. Day range $0.10–$0.11, opened at $0.11.

Last close$0.11+0.18%
Day range0.10–0.11
Open0.11
Volume246.87K
52-week range0.09–1.72
Avg volume (20d)492.47K

HKPD daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” HKPD ends flat (+0.2%) to $0.11
Oct 15, 2026 β€” HKPD dips 2.7% to $0.11
Oct 14, 2026 β€” HKPD jumps 7.6% to $0.11
Oct 13, 2026 β€” HKPD dips 1.9% to $0.10
Oct 12, 2026 β€” HKPD slides 4.5% to $0.11
Oct 9, 2026 β€” HKPD jumps 10.9% to $0.11
Oct 8, 2026 β€” HKPD dips 2.9% to $0.10, a 52-week low
Oct 7, 2026 β€” HKPD rises 1.0% to $0.10
Oct 6, 2026 β€” HKPD dips 1.0% to $0.10, a 52-week low, 4 down days in a row
Oct 5, 2026 β€” HKPD slides 5.5% to $0.10, a 52-week low, 3 down days in a row
Oct 2, 2026 β€” HKPD dips 1.8% to $0.11

HKPD latest news & SEC filings

Every SEC filing by or about HKPD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Sep 24, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-102776

Sep 23, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-102385

Sep 10, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-098532

Aug 13, 2026 Β· Form S-8 β€” Employee share plan registration

Registration of shares for employee stock plans (S-8)

Source: SEC EDGAR filing 0001213900-26-089057

Aug 7, 2026 Β· Form 20-F β€” Annual report from a foreign company (20-F)

Annual report from a foreign company (20-F)

Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).

Source: SEC EDGAR filing 0001213900-26-086725

Jul 31, 2026 Β· Form NT 20-F β€” NT 20-F filing

NT 20-F filing

Source: SEC EDGAR filing 0001213900-26-084011

Jul 16, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-078733

Jun 24, 2026 Β· Form EFFECT β€” EFFECT filing

EFFECT filing

Source: SEC EDGAR filing 9999999995-26-002111

Things to know before you trade HKPD

HKPD market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20260.110.110.100.11246.87K
Oct 15, 20260.100.110.100.11151.10K
Oct 14, 20260.100.110.100.11255.90K
Oct 13, 20260.100.110.100.1065.20K
Oct 12, 20260.110.110.100.11240.10K
Oct 9, 20260.100.110.090.11388.00K
Oct 8, 20260.100.100.090.10604.00K
Oct 7, 20260.100.110.100.10429.00K
Oct 6, 20260.100.110.100.10545.20K
Oct 5, 20260.110.110.100.102.67M
Oct 2, 20260.110.110.110.11253.80K
Oct 1, 20260.110.120.110.11217.40K
Sep 30, 20260.110.120.100.12648.00K
Sep 29, 20260.110.120.100.11510.00K
Sep 28, 20260.110.110.110.11487.00K
Sep 25, 20260.120.120.110.11565.00K
Sep 24, 20260.120.120.120.12311.90K
Sep 23, 20260.120.120.120.12474.00K
Sep 22, 20260.120.120.120.12448.60K
Sep 21, 20260.110.120.110.12335.40K

About Cellyan Biotechnology

Cellyan Biotechnology (HKPD) is listed on the Nasdaq and classified by the SEC under β€œWholesale-Drugs, Proprietaries & Druggists' Sundries”. Its business address is in KOWLOON. State of incorporation: Cayman Islands. Fiscal year ends March 31. SEC CIK 2007702.

HKPD board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Kam Leung ChanDirectorJun 12, 2026
Chenyu Andy LiangCEO and DirectorJun 8, 2026
Lap Sun WongDirectorJun 10, 2026
Jingyan WuDirectorJun 8, 2026
Mike Yao ZhouDirectorJun 8, 2026

Executive officers

NameTitleLatest filing
Chenyu Andy LiangCEO and DirectorJun 8, 2026
Shu LiuCFOJun 8, 2026
Zifeng WangChief Strategy OfficerJun 9, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

HKPD financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

HKPD earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Wholesale-Drugs, Proprietaries & Druggists' Sundries

Mckesson (MCK)Cardinal Health (CAH)Cencora (COR)DataMeds AI (MEDS)Herbalife (HLF)Nu Skin Enterprises (NUS)Cosmos Health (COSM)HWH International (ESYN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on HKPD

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.